CoLucid Pharmaceuticals, Inc.
DelistedCIK 1348649fmd_0WXJZ98WV1J13XEQSHZVS8097CManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2016, 12 periods
| Line item | FY2013 | FY2014 | FY2015 |
|---|---|---|---|
| Research and development | – | 1 | 22 |
| Total operating expenses | – | 2 | 31 |
| Operating income | – | (2) | (31) |
| Interest expense | – | 0 | – |
| Interest and investment income | – | 0 | 0 |
| Other non-operating income (expense) | – | (0) | 0 |
| Income before taxes | – | (3) | (31) |
| Income tax expense | – | 0 | – |
| Net income from continuing operations | – | (3) | – |
| Net income | (2) | (3) | (31) |
| Net income to common shareholders | – | (3) | (39) |